Condition
Rectal Cancer, Radiotherapy
Total Trials
5
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (2)
Trial Status
Recruiting2
Unknown1
Not Yet Recruiting1
Active Not Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06837831Not ApplicableRecruitingPrimary
Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin
NCT07198165Phase 2Recruiting
SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC
NCT07035600Not ApplicableNot Yet Recruiting
Walking and Sitting Difficulties After Rectal Cancer Surgery
NCT06730035Not ApplicableActive Not RecruitingPrimary
PRediction of Outcomes and PERsonalized Radiotherapy by Biomarkers and Functional Imaging
NCT02941562Phase 2UnknownPrimary
A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT
Showing all 5 trials